Thus, a suitable selection of NKG2A+ or NKG2A− Vδ2 T cells for expansion or engineering could help to narrow the Vδ2 T cell population according to the expression of HLA-E on tumor cells. This evidence concerns the gene KLRC1 and neoplasm.